# Safety Study of Three Formulations of the Dermal Implant ELAPR

> **NCT01467778** · PHASE1 · COMPLETED · sponsor: **Elastagen Pty Ltd** · enrollment: 14 (actual)

## Conditions studied

- Skin Conditions

## Interventions

- **DEVICE:** ELAPR
- **DEVICE:** ELAPR

## Key facts

- **NCT ID:** NCT01467778
- **Lead sponsor:** Elastagen Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2011-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01467778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01467778, "Safety Study of Three Formulations of the Dermal Implant ELAPR". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01467778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*